Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes.

Wu, Hongjiang; Lau, Eric S H; Yang, Aimin; Fan, Baoqi; Ma, Ronald C W; Kong, Alice P S; Chow, Elaine; So, Wing-Yee; Chan, Juliana C N; Luk, Andrea O Y

Wu, Hongjiang; Lau, Eric S H; Yang, Aimin; Fan, Baoqi; Ma, Ronald C W; Kong, Alice P S; Chow, Elaine; So, Wing-Yee; Chan, Juliana C N; Luk, Andrea O Y.

Afiliação

Wu H; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Lau ESH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Yang A; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Fan B; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
Ma RCW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Kong APS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Chow E; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
So WY; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Chan JCN; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Luk AOY; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.

Diabetes Metab Res Rev ; 39(4): e3615, 2023 05.

Article em En | MEDLINE | ID: mdl-36652944

Assuntos

Diabetes Mellitus Tipo 2; Inibidores da Dipeptidil Peptidase IV; Metformina; Masculino; Humanos; Diabetes Mellitus Tipo 2/complicações; Diabetes Mellitus Tipo 2/tratamento farmacológico; Diabetes Mellitus Tipo 2/diagnóstico; Glucose; População do Leste Asiático; Hipoglicemiantes/uso terapêutico; Hipoglicemiantes/farmacologia; Metformina/uso terapêutico; Metformina/farmacologia; Compostos de Sulfonilureia/uso terapêutico; Inibidores da Dipeptidil Peptidase IV/uso terapêutico; Inibidores da Dipeptidil Peptidase IV/farmacologia

Palavras-chave

Chinese; glucose lowering drugs; glycaemic response; predictors; type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Metformina Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google